Quidel Corp. (QDEL) announced that it expects revenues in the fourth quarter 2012 in the range of $53 million to $54 million.
Analysts polled by Thomson Reuters expect the company to report fourth-quarter revenue of $43.84 million.
Douglas Bryant, president and chief executive officer, said "We saw a sudden and early onset to this year's influenza season. While QuickVue Influenza A+B sales benefited most from the patient visits for influenza-like illness in the quarter, Sofia Influenza A+B revenues were a contributor as well, driven by numerous Sofia analyzer placements, the number of which also exceeded internal projections. Currently, our placements exceed 3,000 Sofia instruments, a high percentage of which are installed and on-line."
For comments and feedback: editorial@rttnews.com